Results 51 to 60 of about 785 (150)

The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort

open access: yesFrontiers in Immunology, 2022
The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessively inherited disease that has undergone extensive phenotypic expansion since being first described in patients with fevers, recurrent strokes, livedo racemosa, and polyarteritis ...
Karyl S. Barron   +30 more
doaj   +1 more source

Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2

open access: yesFrontiers in Pediatrics, 2018
Deficiency of adenosine deaminase 2 (DADA2) is a monogenic form of systemic vasculopathy that often presents during early childhood. Linked to biallelic mutations in ADA2 (previously CECR1), DADA2 was initially described as a syndrome of recurrent fever,
Pui Y. Lee
doaj   +1 more source

Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series

open access: yesPediatric Rheumatology Online Journal, 2022
Background/purpose Pediatric antiphospholipid syndrome (APS) is a thromboinflammatory disease characterized by the presence of circulating antiphospholipid antibodies and either thrombotic events or pregnancy morbidity. The objective of this study was to
Jacqueline A. Madison   +5 more
doaj   +1 more source

Cutaneous Manifestations of COVID‐19: A Descriptive Analysis of a Southeastern USA Purposive Sample

open access: yesInternational Wound Journal, Volume 22, Issue 4, April 2025.
ABSTRACT This study describes characteristics and factors associated with cutaneous manifestations of COVID‐19 encountered across acute inpatient, and critical care units in a large Southeastern USA public hospital from March 1, 2020, through November 01, 2021.
Shannon S. Layton   +5 more
wiley   +1 more source

Sneddon syndrome

open access: yesThe Pan African Medical Journal, 2019
Sneddon's syndrome (SS) is a rare non-inflammatory thrombotic vasculopathy characterized by the combination of cerebrovascular disease with livedo racemosa(LR).
Hakima Elmahi, Fatima Zahra Mernissi
doaj   +1 more source

Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review

open access: yesBiology, 2020
There have been increasing reports of skin manifestations in COVID-19 patients. We conducted a systematic review and included manuscripts describing patients with positive RT-PCR coronavirus testing from nasopharyngeal swabs who also developed cutaneous ...
Claudio Conforti   +10 more
doaj   +1 more source

Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System

open access: yesPharmacology Research &Perspectives, Volume 13, Issue 1, February 2025.
ABSTRACT The increasing utilization of cannabis products combined with lack of data regarding potential cannabis–prescription drug interactions is concerning. This study aimed to review published case reports and FDA Adverse Event Reporting System (FAERS) spontaneous reports to assess cannabis–drug interactions in persons aged 18 and over. A literature
Maryann R. Chapin   +7 more
wiley   +1 more source

#92.Livedoid Vasculopathy-Induced Peripheral Neuropathy Treated Successfully With Aspirin, Rivaroxaban, and Pentoxifylline

open access: yesGraduate Medical Education Research Journal
Mentor: Megan Arthur Program: Dermatology Type: Case Report Background: Livedo Vasculopathy (LV) is a chronic cutaneous thrombo-occlusive disorder, presenting with purpuric patches and painful skin ulcerations due to micro-thrombosis of dermal vessels ...
Priscilla M. Rosa-Nieves   +3 more
doaj   +1 more source

Wound, pressure ulcer, and burn guidelines (2023)―4: Guidelines for the management of connective tissue disease/vasculitis‐associated skin ulcers, third edition

open access: yes
The Journal of Dermatology, Volume 52, Issue 6, Page e430-e480, June 2025.
Yoshihide Asano   +27 more
wiley   +1 more source

Misdiagnosed for 14 Years: Adenosine Deaminase 2 (ADA2) Deficiency in a Teen Mimicking Polyarteritis Nodosa

open access: yesClinical Case Reports, Volume 12, Issue 11, November 2024.
ABSTRACT The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disorder caused by loss of function mutations in the ADA2 gene (previously the CECR1 gene) on chromosome 22q11. The clinical spectrum of the disease is remarkably broad, and its presentations mimic features of polyarteritis nodosa, such as livedoid rash, hematological ...
Mohammadkian Zarafshani   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy